Investing News Network

投资新闻网

September 08, 2025

2025年9月8日

Seegnal Inc. (TSXV: SEGN)

希格纳尔公司（TSXV：SEGN）

('

('

Seegnal

信号

' or the '

' 或者 '

Corporation

公司

'), a global leader in SaaS clinical division support solutions, is pleased to announce that effective September 8, 2025, it has amended its contract with Maccabi Health Services ('

“），作为SaaS临床部门支持解决方案的全球领导者，欣然宣布自2025年9月8日起，已与马卡比健康服务公司（"

Maccabi

麦卡比

') for an additional six years and has also expanded the scope of the contract to include all of Maccabi's pharmacies and additional nurses. Maccabi is the second largest Healthcare Management Organization ('

''）额外六年，并且还扩大了合同范围，包括马卡比的所有药店和更多的护士。马卡比是第二大医疗管理组织（

HMO

健康维护组织

') in Israel, serving over 2.6 million Israelis and is renowned for its use of technology and emphasis on patient-centered care, according to Maccabi's website

`) 在以色列，为超过 260 万以色列人提供服务，并因其对技术和以患者为中心的护理的重视而闻名，根据马卡比的网站

here

这里

.

。

Pursuant to the amended agreement, Seegnal will continue to deliver its patented prescription co-pilot platform for an additional six years, to September 22, 2031, while expanding the scope to nurses and pharmacists in all of Maccabi's nationwide pharmacies. Maccabi is the first in Israel and one of the first HMOs worldwide to offer an end-to-end safety coverage throughout the patient journey, allowing complete visibility to pharmacists in the pharmacies into clinician decision while prescribing patient centric medication.

根据修订后的协议，Seegnal 将继续提供其获得专利的处方辅助平台，为期六年，至 2031 年 9 月 22 日，并将范围扩大到 Maccabi 全国所有药房的护士和药剂师。Maccabi 是以色列首家，也是全球最早提供覆盖患者全程安全服务的健康维护组织（HMO）之一，使药房中的药剂师能够完全了解临床医生在开患者中心药物时的决策过程。

The expanded contract was changed from a fixed base contract to Seegnal's current SaaS based model based on Quarterly Recurring License Fees and is expected to generate additional revenue for the Corporation..

扩展合同从固定基础合同变更为Seegnal当前基于季度经常性许可费的SaaS模式，预计将为公司带来额外收入。

“This partnership is a testament to the measurable impact Seegnal delivers for Healthcare providers who adopt a high patient-centric standard at the point of care over the traditional Drug-to-Drug Interaction (DDI) standard,” said Eyal Schneid, CEO of Seegnal. “We’re proud to deepen our relationship with Maccabi Health Services and bring even greater precision, safety, and efficiency to their clinical and operative workflows.

“这一合作关系证明了Seegnal为采用以患者为中心的高标准医疗保健提供者所带来的可衡量影响，超越了传统的药物相互作用（DDI）标准，”Seegnal首席执行官Eyal Schneid表示。“我们很自豪能够深化与Maccabi卫生服务的合作关系，为他们的临床和操作流程带来更高的精确性、安全性和效率。”

This expansion also reinforces our strategic growth trajectory and positions us to scale our impact across broader markets.”.

此次扩展还加强了我们的战略增长轨迹，并使我们能够扩大在更广阔市场中的影响力。

Mr. Schneid added, “The new agreement extends through September 22, 2031, with an option for Maccabi to extend it further by two years under the current terms. It broadens the integration beyond the Electronic Health Record (EHR) to the ERP system nationwide. It reflects growing demand for Seegnal’s platform, which in a 2021 study published in the US National Library of Medicine titled “.

施耐德先生补充道：“新协议延长至2031年9月22日，麦克比有权选择在当前条款下再延长两年。该协议扩大了电子健康记录（EHR）以外的整合范围，推广至全国的ERP系统。这反映了市场对Seegnal平台日益增长的需求，正如2021年在美国国家医学图书馆发表的一项研究中所述，题为‘’。”

Comparison of Medication Alerts from Two Commercial Applications in the USA

美国两种商业应用的药物警报比较

” and located online here, demonstrated the ability to reduce alert load by up to 94%, lower medication-related costs, and improve clinician satisfaction—key metrics that align with value-based care initiatives and payer priorities.”

“并在线提供，证明了能够将警报负载减少多达 94％，降低与药物相关的成本，并提高临床医生的满意度——这些关键指标与基于价值的护理计划和支付方优先事项相一致。”

'

'

Maccabi Health Services

马卡比医疗服务中心

has been a partner in embracing

一直是拥抱的伙伴

customer-centric medication standards,' added Schneid. 'Together, we're setting a new standard for proactive, patient-specific care. This milestone further validates our commercial strategy and underscores the scalability of our technology.'

“以客户为中心的药物标准，”施耐德补充道。“我们共同为积极的、针对患者的护理设定了新标准。这一里程碑进一步验证了我们的商业战略，并突显了我们技术的可扩展性。”

About Seegnal

关于Seegnal

Seegnal is a public company that aims to solve one of the top causes of death and injuries in the modern world – Adverse Drug Effects (ADEs). Seegnal's Clinical Decision Support system introduces a paradigm shift in the approach to this problem by implementing a new elevated Patient-Centric Standard.

Seegnal是一家上市公司，旨在解决现代世界中导致死亡和伤害的主要原因之一——药物不良反应（ADEs）。Seegnal的临床决策支持系统通过实施新的提升型以患者为中心的标准，为解决这一问题带来了范式转变。

Seegnal's SaaS technology exclusively integrates at the point-of-care, unique patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age, and the effects of many concomitant medications, while reducing the current alert load for clinicians by over 90%. In practice, clinicians using Seegnal eHealth complete their prescription workflow with limited interruption, saving time and fatigue.

Seegnal的SaaS技术在诊疗点独家整合了独特的患者特定数据，如基因、实验室检测结果、心电图、吸烟、过敏、食物、性别、年龄以及多种合并用药的影响，同时将临床医生当前的警报负担减少了90%以上。在实践中，使用Seegnal电子健康的临床医生能够以极少的中断完成处方工作流程，节省了时间和精力。

Similarly, patients enjoy more tailored medication and improved safety, leading to better quality of life, due to the precision of alerts with up to 98% accuracy. Institutions reported a reduction in admissions, medication consumption, and ample time savings in prescription renewals. Seegnal eHealth is marketing its SaaS-based platform in the State of Israel (where recently the Ministry of Health has adopted Seegnal's patient-specific standard as the new standard in governmental hospitals), the UAE, the United Kingdom, the United States, and Poland.

同样，由于警报的精确性高达98%的准确率，患者享受到更加个性化的药物治疗和更高的安全性，从而提升了生活质量。机构报告称住院人数减少、药物消耗降低，并且在处方续签上节省了大量时间。Seegnal eHealth正在以色列（最近以色列卫生部已采用Seegnal的针对患者的标准作为政府医院的新标准）、阿联酋、英国、美国和波兰推广其基于SaaS平台的服务。

The platform is currently a 'standard of care' system for over 10,000 clinicians in Israel, used on a daily basis for prescribing medications to their patients..

该平台目前是以色列超过10,000名临床医生的“标准护理”系统，每天用于为患者开处方药。

See

看见

www.seegnal.com

www.seegnal.com

About Maccabi Health Services

关于马卡比健康服务

'Maccabi Healthcare Services' (formerly known as Maccabi HMO) is one of the four HMOs operating in Israel. Founded in September 1940, Maccabi began providing medical services in August 1941. Today, 'Maccabi Healthcare Services' boasts more than 2.6 million members and is recognized as one of the most influential institutions shaping Israel's health system.

'Maccabi Healthcare Services'（前身为 Maccabi HMO）是以色列运营的四家健康维护组织（HMO）之一。该组织成立于1940年9月，于1941年8月开始提供医疗服务。如今，'Maccabi Healthcare Services' 拥有超过260万成员，被认为是塑造以色列卫生系统最有影响力的机构之一。

Maccabi provides its members with top-tier medical services, emphasizing holistic health, promoting preventive health and medicine, and upholding the founders' core values of free choice, medical quality, balanced economics, and efficiency. In recent years, we've observed rapid changes in the healthcare landscape, including shifts in concepts of health, advancements in technology, regulatory changes, and more.

麦克凯比为其成员提供顶级的医疗服务，强调整体健康，促进预防性健康和医学的发展，并坚持创始人的核心价值观：自由选择、医疗质量、经济平衡和效率。近年来，我们观察到医疗保健领域发生了迅速的变化，包括健康观念的转变、技术的进步、监管的变化等等。

In response to these changes, Maccabi's mission is to be a leading health organization in a dynamic environment, shaping the future of medicine for the holistic well-being of Maccabi members..

面对这些变化，马卡比的使命是成为动态环境中的领先健康组织，为马卡比成员的整体福祉塑造医学的未来。

See

看见

https://www.maccabi4u.co.il/en/46562/main_english/our-healthcare-system/about/

https://www.maccabi4u.co.il/en/46562/main_english/our-healthcare-system/about/

Seegnal Media Contact:

Seegnal 媒体联系人：

Eyal Schneid

施内德，埃亚勒

Chief Executive Officer

首席执行官

press@seegnal.com

press@seegnal.com

+972-54-477-0558

+972-54-477-0558

www.seegnal.com

www.seegnal.com

Forward-Looking Information

前瞻性信息

This press release contains 'forward-looking information' or 'forward-looking statements' within the meaning of Canadian securities legislation. All statements included herein, other than statements of historical fact, including statements included in the 'About Seegnal' section of this press release, are forward-looking.

本新闻稿包含加拿大证券立法意义上的“前瞻性信息”或“前瞻性陈述”。本新闻稿中包含的所有陈述，除历史事实陈述外，包括本新闻稿“关于Seegnal”部分中的陈述，均为前瞻性陈述。

Generally, the forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as 'anticipate', 'believes', 'estimates', 'expects', 'intends', 'may', 'should', 'will' or variations of such words or similar expressions. More particularly, and without limitation, this press release contains forward-looking information or forward-looking statements concerning future revenue and opportunities resulting from the Corporation's amended contract with Maccabi and the benefits to clinicians and patients.

一般来说，前瞻性信息和前瞻性陈述可以通过使用前瞻性术语来识别，例如“预期”、“相信”、“估计”、“预计”、“意图”、“可能”、“应该”、“将”或这些词语或类似表达的变化。更具体地说，且不限于此，本新闻稿包含有关公司与Maccabi修订合同后带来的未来收入和机会以及对临床医生和患者的益处的前瞻性信息或前瞻性陈述。

Seegnal cautions that all forward-looking information and forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, assumptions and expectations, many of which are beyond the control of Seegnal, including expectations and assumptions concerning Seegnal and its products as well as other risks and uncertainties, including those described in Seegnal's filings available on SEDAR+ at .

Seegnal提醒，所有前瞻性信息和前瞻性陈述均存在固有的不确定性，实际表现可能受到许多重要因素、假设和预期的影响，其中许多因素超出了Seegnal的控制范围，包括与Seegnal及其产品相关的预期和假设，以及其他风险和不确定性，包括在SEDAR+上Seegnal的文件中描述的那些风险和不确定性。

www.sedarplus.ca

www.sedarplus.ca

. The reader is cautioned that assumptions used in the preparation of any forward-looking information or forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of Seegnal.

读者应注意，用于编制任何前瞻性信息或前瞻性陈述的假设可能被证明是不正确的。事件或情况可能导致实际结果与由于众多已知和未知风险、不确定性和其他因素（其中许多是Seegnal无法控制的）所预测的结果有重大差异。

The reader is cautioned not to place undue reliance on any forward-looking information or forward-looking statements. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking information and forward-looking statements contained in this press release are expressly qualified by this cautionary statement..

读者被提醒不要对任何前瞻性信息或前瞻性陈述施加过度依赖。此类信息虽然在管理层准备时认为是合理的，但可能被证明是不正确的，实际结果可能与预期有重大差异。本新闻稿中包含的前瞻性信息和前瞻性陈述均受此警示声明明确限定。

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Seegnal does not undertake any obligation to update publicly or to revise any of the included forward-looking information or forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law..

本新闻稿中包含的前瞻性信息和前瞻性声明是截至本新闻稿发布之日作出的，Seegnal 没有义务公开更新或修改任何包含的前瞻性信息或前瞻性声明，无论是否由于新信息、未来事件或其他原因，除非法律明确要求。

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所创业板及其监管服务提供商（该术语在多伦多证券交易所创业板的政策中有定义）均不对本公告的充分性或准确性承担责任。

The securities have not been and will not be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful..

这些证券尚未也不会根据修订后的《1933年美国证券法》进行注册，且在未注册或未获得适用的注册豁免的情况下，不得在美国境内提供或出售。本新闻稿不构成出售要约或购买要约的邀请，也不得在任何此类要约、邀请或销售属于违法的司法管辖区出售该等证券。

Source

源代码

tsxv:segn

tsxv:segn

tsxv stocks

TSXV 股票

biotech investing

生物技术投资

medical device investing

医疗器械投资

pharmaceutical investing

医药投资

SEGN:CA

SEGN:CA